Sign In
Buy CL
Colgate-Palmolive Company Earnings Calls
| Release date | May 01, 2026 |
| EPS estimate | $0.94 |
| EPS actual | $0.97 |
| EPS Surprise | 2.86% |
| Revenue estimate | 5.216B |
| Revenue actual | 5.324B |
| Revenue Surprise | 2.07% |
| Release date | Jan 30, 2026 |
| EPS estimate | $0.91 |
| EPS actual | $0.95 |
| EPS Surprise | 4.17% |
| Revenue estimate | 5.123B |
| Revenue actual | 5.23B |
| Revenue Surprise | 2.09% |
| Release date | Oct 31, 2025 |
| EPS estimate | $0.89 |
| EPS actual | $0.91 |
| EPS Surprise | 2.36% |
| Revenue estimate | 5.127B |
| Revenue actual | 5.131B |
| Revenue Surprise | 0.0764% |
| Release date | Aug 01, 2025 |
| EPS estimate | $0.90 |
| EPS actual | $0.92 |
| EPS Surprise | 2.56% |
| Revenue estimate | 5.036B |
| Revenue actual | 5.11B |
| Revenue Surprise | 1.48% |
Last 4 Quarters for Colgate-Palmolive Company
Below you can see how CL performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 01, 2025 |
| Price on release | $83.51 |
| EPS estimate | $0.90 |
| EPS actual | $0.92 |
| EPS surprise | 2.56% |
| Date | Price |
|---|---|
| Jul 28, 2025 | $86.47 |
| Jul 29, 2025 | $86.86 |
| Jul 30, 2025 | $85.80 |
| Jul 31, 2025 | $83.85 |
| Aug 01, 2025 | $83.51 |
| Aug 04, 2025 | $83.36 |
| Aug 05, 2025 | $83.06 |
| Aug 06, 2025 | $84.61 |
| Aug 07, 2025 | $84.71 |
| 4 days before | -3.42% |
| 4 days after | 1.44% |
| On release day | -0.180% |
| Change in period | -2.04% |
| Release date | Oct 31, 2025 |
| Price on release | $77.05 |
| EPS estimate | $0.89 |
| EPS actual | $0.91 |
| EPS surprise | 2.36% |
| Date | Price |
|---|---|
| Oct 27, 2025 | $77.83 |
| Oct 28, 2025 | $77.14 |
| Oct 29, 2025 | $75.73 |
| Oct 30, 2025 | $76.51 |
| Oct 31, 2025 | $77.05 |
| Nov 03, 2025 | $74.98 |
| Nov 04, 2025 | $76.55 |
| Nov 05, 2025 | $76.91 |
| Nov 06, 2025 | $77.27 |
| 4 days before | -1.00% |
| 4 days after | 0.286% |
| On release day | -2.69% |
| Change in period | -0.720% |
| Release date | Jan 30, 2026 |
| Price on release | $90.29 |
| EPS estimate | $0.91 |
| EPS actual | $0.95 |
| EPS surprise | 4.17% |
| Date | Price |
|---|---|
| Jan 26, 2026 | $85.20 |
| Jan 27, 2026 | $85.76 |
| Jan 28, 2026 | $85.00 |
| Jan 29, 2026 | $85.24 |
| Jan 30, 2026 | $90.29 |
| Feb 02, 2026 | $91.89 |
| Feb 03, 2026 | $93.15 |
| Feb 04, 2026 | $94.37 |
| Feb 05, 2026 | $94.88 |
| 4 days before | 5.97% |
| 4 days after | 5.08% |
| On release day | 1.77% |
| Change in period | 11.36% |
| Release date | May 01, 2026 |
| Price on release | $87.26 |
| EPS estimate | $0.94 |
| EPS actual | $0.97 |
| EPS surprise | 2.86% |
| Date | Price |
|---|---|
| Apr 27, 2026 | $84.17 |
| Apr 28, 2026 | $85.68 |
| Apr 29, 2026 | $84.49 |
| Apr 30, 2026 | $85.36 |
| May 01, 2026 | $87.26 |
| May 04, 2026 | $85.37 |
| May 05, 2026 | $86.33 |
| May 06, 2026 | $88.16 |
| May 07, 2026 | $87.36 |
| 4 days before | 3.67% |
| 4 days after | 0.115% |
| On release day | -2.17% |
| Change in period | 3.79% |
Colgate-Palmolive Company Earnings Call Transcript Summary of Q1 2026
Colgate-Palmolive reported a strong start to FY2026 with accelerating organic sales growth and improved volume performance, led by emerging markets (notably Asia Pacific and Latin America). The company grew both volume and pricing across most categories and divisions (excluding the impact of exiting private-label pet food), and Hill's Pet Nutrition performed particularly well. Management is maintaining full-year top- and bottom-line guidance (organic sales growth 1%–4%; EPS low- to mid-single digits) but lowered gross margin expectations due to an incremental ~$300 million of raw-material and logistics inflation embedded in guidance (assumes oil ~ $110/bbl). Key mitigants include active RGM (revenue growth management), pricing tied to premium innovation, ongoing productivity programs (SGPP) with updated expected savings of $200–$300 million through 2027–2028 (program still concludes 2028), and continued investment behind brands, digital, AI and omnichannel marketing. Near-term risks called out: commodity/oil price volatility, tariffs impacting North America gross margins, and consumer demand sensitivity. Management expects sequential improvement in North America as recent innovations and execution take hold.
